VNCE Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Not a good buy right now for an impatient investor. VNCE is drifting below its pivot with bearish momentum (MACD below zero) and no proprietary buy signals today. While the single analyst update is bullish and fundamentals show revenue growth, profitability/EPS are declining, and the probabilistic trend suggests downside over the next month. I would wait for a clearer technical reversal (reclaiming ~2.75–3.01) before buying; otherwise it’s a hold/avoid new entry here.
Price/levels: Closed at 2.725 (down ~3.9% vs prior close 2.81), sitting just below the pivot (2.75). Nearby support is S1 2.494 then S2 2.336; resistance is R1 3.006 then R2 3.164. Momentum: MACD histogram is negative (-0.0396) but contracting, implying bearish momentum is weakening (potential early stabilization, not a confirmed reversal). RSI: RSI(6) at ~37 is weak but not deeply oversold; it signals pressure remains and a bounce is not yet high-confidence. Trend/structure: Moving averages are converging, consistent with consolidation after a drop. Pattern-based outlook: Similar-pattern stats imply modest upside short-term (next week +1.74%) but negative bias over the next month (-7.59%), which is unfavorable for an impatient entry. Tactical read: A higher-quality buy would be on a reclaim and hold above ~2.75–3.01; a breakdown below ~2.49 increases downside risk toward ~2.34.
reiterated Outperform and raised PT to $5.50 from $4.50, citing improved operating execution and a higher peer-aligned multiple.
Margin pressure: Gross margin declined 1.48% YoY to 49.23, suggesting higher costs/promotions or mix headwinds.
Latest quarter: 2026/Q3. Growth: Revenue increased 6.19% YoY to $85.13M. Earnings quality: Net income decreased 37.32% YoY to $2.73M; EPS decreased 38.24% YoY to $0.21. Margins: Gross margin slipped to 49.23% (down 1.48% YoY). Takeaway: Top-line growth is positive, but the quarter shows meaningful profit/EPS compression—fundamentals are mixed and not ideal for chasing a quick upside move.
Recent trend: One notable update—on 2026-01-05 Noble Capital raised its price target to $5.50 from $4.50 and maintained an Outperform rating, citing improved execution and a more peer-consistent valuation multiple. Wall Street pros: Bullish PT increase implies perceived re-rating potential if execution continues; acknowledges operational improvement. Wall Street cons: Limited coverage signal (only one cited update) and the latest quarter showed earnings/margin declines, which can cap near-term multiple expansion. Net read: Analyst sentiment is positive, but it is currently outweighed by weak near-term technicals and declining profitability for a buy-right-now decision.
